Technical Analysis for FGEN - FibroGen, Inc

Grade Last Price % Change Price Change
D 2.17 3.83% 0.08
FGEN closed up 3.83 percent on Monday, March 18, 2024, on 88 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Gapped Up Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 3.83%
Doji - Bearish? Reversal 3.83%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 12 hours ago
Possible Pocket Pivot about 13 hours ago
Up 10% about 13 hours ago
Rose Above Previous Day's High about 13 hours ago
Outside Day about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

FibroGen, Inc Description

FibroGen, Inc. operates as a research-based biopharmaceutical company in the United States. The company focuses on the discovery, development, and commercialization of therapeutic agents to treat serious unmet medical needs. The company develops roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019, a monoclonal antibody, which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. It also focuses on use of the proprietary type III recombinant human collagens in its biosynthetic corneal implant product candidate, FG-5200 for the treatment of corneal blindness. The company was incorporated in 1993 and is headquartered in San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Clinical Development Monoclonal Antibody Kidney Disease Pancreatic Cancer Anemia Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Chronic Kidney Disease Blindness Cornea Collagen Liver Fibrosis Treatment Of Idiopathic Pulmonary Fibrosis Hypoxia Inducible Factors

Is FGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.9
52 Week Low 0.3345
Average Volume 2,915,173
200-Day Moving Average 2.56
50-Day Moving Average 1.66
20-Day Moving Average 1.90
10-Day Moving Average 1.93
Average True Range 0.28
RSI (14) 59.02
ADX 26.92
+DI 23.73
-DI 11.71
Chandelier Exit (Long, 3 ATRs) 1.52
Chandelier Exit (Short, 3 ATRs) 2.42
Upper Bollinger Bands 2.17
Lower Bollinger Band 1.63
Percent B (%b) 0.99
BandWidth 28.65
MACD Line 0.08
MACD Signal Line 0.07
MACD Histogram 0.0063
Fundamentals Value
Market Cap 213.4 Million
Num Shares 98.3 Million
EPS -3.06
Price-to-Earnings (P/E) Ratio -0.71
Price-to-Sales 1.71
Price-to-Book 53.83
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.78
Resistance 3 (R3) 2.78 2.57 2.68
Resistance 2 (R2) 2.57 2.41 2.57 2.65
Resistance 1 (R1) 2.37 2.32 2.37 2.37 2.61
Pivot Point 2.16 2.16 2.16 2.16 2.16
Support 1 (S1) 1.96 2.00 1.97 1.97 1.73
Support 2 (S2) 1.75 1.91 1.75 1.69
Support 3 (S3) 1.55 1.75 1.66
Support 4 (S4) 1.56